Greg Hather

754 total citations
22 papers, 547 citations indexed

About

Greg Hather is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Greg Hather has authored 22 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Greg Hather's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Mosquito-borne diseases and control (4 papers). Greg Hather is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Mosquito-borne diseases and control (4 papers). Greg Hather collaborates with scholars based in United States, United Kingdom and Germany. Greg Hather's co-authors include Mary C. Wildermuth, Divya Chandran, Noriko Inada, Javaria Mona Khalid, Edward V. Loftus, Stefan Schreiber, Laurent Peyrin‐Biroulet, Axel Dignaß, Mahmoud Mosli and Dirk Demuth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Greg Hather

21 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Hather United States 11 206 139 137 133 76 22 547
Marc J. Eleveld Netherlands 21 456 2.2× 214 1.5× 62 0.5× 240 1.8× 40 0.5× 42 919
Rebecca Parr United States 11 240 1.2× 85 0.6× 30 0.2× 45 0.3× 81 1.1× 13 518
Jeong-Hee Lee South Korea 10 96 0.5× 43 0.3× 142 1.0× 42 0.3× 47 0.6× 29 362
Rebecca J. Davis Australia 11 165 0.8× 73 0.5× 14 0.1× 135 1.0× 106 1.4× 27 464
María Lourdes Garza-Rodríguez Mexico 11 171 0.8× 211 1.5× 20 0.1× 46 0.3× 41 0.5× 43 507
Yawen Zou China 17 396 1.9× 64 0.5× 26 0.2× 191 1.4× 94 1.2× 44 754
Gudrun Stamminger Germany 11 143 0.7× 188 1.4× 54 0.4× 131 1.0× 156 2.1× 29 599
Ya‐Fang Chiu Taiwan 15 132 0.6× 306 2.2× 35 0.3× 30 0.2× 339 4.5× 30 634
Chuan Young Ng Singapore 8 208 1.0× 55 0.4× 20 0.1× 37 0.3× 42 0.6× 10 462
Tianyang Li China 11 91 0.4× 168 1.2× 36 0.3× 36 0.3× 38 0.5× 19 463

Countries citing papers authored by Greg Hather

Since Specialization
Citations

This map shows the geographic impact of Greg Hather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Hather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Hather more than expected).

Fields of papers citing papers by Greg Hather

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Hather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Hather. The network helps show where Greg Hather may publish in the future.

Co-authorship network of co-authors of Greg Hather

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Hather. A scholar is included among the top collaborators of Greg Hather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Hather. Greg Hather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Lin, Dean Bottino, Greg Hather, et al.. (2023). Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines. 11(4). 806–806. 2 indexed citations
2.
DeMaso, Christina R., et al.. (2022). Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine. The Journal of Infectious Diseases. 226(11). 1959–1963. 8 indexed citations
3.
Bottino, Dean, et al.. (2021). Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection. PubMed. 4(3). 144–148. 3 indexed citations
4.
Sonnberg, Stephanie, et al.. (2021). A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species. PLoS ONE. 16(4). e0250516–e0250516. 11 indexed citations
5.
Hibi∥, Toshifumi, Isao Kamae, Philippe Pinton, et al.. (2020). Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis. Intestinal Research. 19(1). 53–61. 15 indexed citations
6.
Young, Ginger, Greg Hather, C. Godin, et al.. (2020). Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection. Scientific Reports. 10(1). 3488–3488. 20 indexed citations
7.
Galaznik, Aaron, et al.. (2019). Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care. Cancer Informatics. 18. 2411581842–2411581842. 4 indexed citations
8.
Izmailova, Elena S., Gaurav Bhatia, Greg Hather, et al.. (2019). Evaluation of Wearable Digital Devices in a Phase I Clinical Trial. Clinical and Translational Science. 12(3). 247–256. 27 indexed citations
9.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2018). Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease. Journal of Gastroenterology. 53(9). 1048–1064. 115 indexed citations
10.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2018). P155 REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS. Gastroenterology. 154(1). S82–S82. 1 indexed citations
11.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2018). P155 REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS. Inflammatory Bowel Diseases. 24(suppl_1). S57–S58. 1 indexed citations
12.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2017). P466 Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis. Journal of Crohn s and Colitis. 11(suppl_1). S315–S315.
13.
Hather, Greg, et al.. (2017). P305 Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumab. Journal of Crohn s and Colitis. 11(suppl_1). S232–S233. 4 indexed citations
14.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2017). Real World Effectiveness of Vedolizumab Over One Year in Inflammatory Bowel Disease: A Meta-Analysis. Gastroenterology. 152(5). S338–S338. 2 indexed citations
15.
Chattopadhyay, Nibedita, Allison Berger, Erik Koenig, et al.. (2015). KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. PLoS ONE. 10(12). e0144825–e0144825. 14 indexed citations
16.
Li, Cong, Can Yang, Greg Hather, Ray Liu, & Hongyu Zhao. (2015). Efficient Drug-Pathway Association Analysis via Integrative Penalized Matrix Decomposition. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 13(3). 531–540. 10 indexed citations
17.
Garcia, Khristofer, Jonathan L. Blank, David C. Bouck, et al.. (2014). Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways. Molecular Cancer Therapeutics. 13(6). 1625–1635. 45 indexed citations
18.
Blank, Jonathan L., Katherine Cosmopoulos, David C. Bouck, et al.. (2012). Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924. Cancer Research. 73(1). 225–234. 85 indexed citations
19.
Chandran, Divya, Greg Hather, & Mary C. Wildermuth. (2011). Global Expression Profiling of RNA from Laser Microdissected Cells at Fungal–Plant Interaction Sites. Methods in molecular biology. 712. 263–281. 2 indexed citations
20.
Chandran, Divya, et al.. (2009). Laser microdissection of Arabidopsis cells at the powdery mildew infection site reveals site-specific processes and regulators. Proceedings of the National Academy of Sciences. 107(1). 460–465. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc J. Eleveld Breakdown of academic impact, for papers by Rebecca Parr Breakdown of academic impact, for papers by Jeong-Hee Lee Breakdown of academic impact, for papers by Rebecca J. Davis Breakdown of academic impact, for papers by María Lourdes Garza-Rodríguez Breakdown of academic impact, for papers by Yawen Zou Breakdown of academic impact, for papers by Gudrun Stamminger Breakdown of academic impact, for papers by Ya‐Fang Chiu Breakdown of academic impact, for papers by Chuan Young Ng Breakdown of academic impact, for papers by Tianyang Li
Rankless by CCL
2026